Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein

We have expressed the human immunodeficiency virus type 1 (HIV-1) gag polyprotein (Pr55gag) in bacteria under the control of the T7 phage gene 10 promoter. When the gene encoding the viral protease is included in cis, in the -1 reading frame, the expected proteolytic cleavage products MA and CA are produced. Disruption of the protease-coding sequence prevents proteolytic processing, and full-length polyprotein is produced. Pr55gag, separated from bacterial proteins by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and immobilized on nitrocellulose membranes, binds RNA containing sequences from the 5' end of the HIV-1 genome. This binding is tolerant of a wide range of pH and temperature but has distinct salt preferences. Conditions were identified which prevented nonspecific binding of RNA to bacterial proteins but still allowed binding to Pr55gag. Under these conditions, irrelevant RNA probes lacking HIV-1 sequences bound Pr55gag less efficiently. Quantitation of binding to Pr55gag by HIV-1 RNA probes with deletions mutations demonstrated that there are two regions lying within the HIV-1 gag gene which independently promote binding of RNA to Pr55gag.

[1]  R. Aronoff,et al.  Specificity of retroviral RNA packaging , 1991, Journal of virology.

[2]  J. Sodroski,et al.  Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector , 1991, Journal of virology.

[3]  J. Orenstein,et al.  A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology , 1990, Journal of virology.

[4]  P. Dupraz,et al.  Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein , 1990, Journal of virology.

[5]  L. Arthur,et al.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA , 1990, Journal of virology.

[6]  R. Young,et al.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus , 1990, Journal of virology.

[7]  J. Walker,et al.  Programmed ribosomal frameshifting generates the Escherichia coli DNA polymerase III gamma subunit from within the tau subunit reading frame. , 1990, Nucleic acids research.

[8]  R. Sauer,et al.  Carboxy-terminal determinants of intracellular protein degradation. , 1990, Genes & development.

[9]  V. Vogt,et al.  RNA-binding properties of the matrix protein (p19gag) of avian sarcoma and leukemia viruses , 1990, Journal of virology.

[10]  I. Pastan,et al.  Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease. , 1990, The Journal of biological chemistry.

[11]  R. Weiss,et al.  E. coli ribosomes re-phase on retroviral frameshift signals at rates ranging from 2 to 50 percent. , 1989, The New biologist.

[12]  E. Jacobs,et al.  Assembly and release of HIV-1 precursor Pr55 gag virus-like particles from recombinant baculovirus-infected insect cells , 1989, Cell.

[13]  J. Sodroski,et al.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions , 1989, Journal of virology.

[14]  J. Sodroski,et al.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Dixon,et al.  Purification and characterization of human immunodeficiency virus (HIV) core precursor (p55) expressed in Saccharomyces cerevisiae. , 1989, The Journal of biological chemistry.

[16]  E. Jacobs,et al.  The HIV-1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane. , 1989, Gene.

[17]  E. Ohtsubo,et al.  Frameshifting is required for production of the transposase encoded by insertion sequence 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Goff,et al.  Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein , 1989, Journal of virology.

[19]  S. Goff,et al.  Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription , 1989, Journal of virology.

[20]  R. Gorelick,et al.  Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Wimmer,et al.  Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli , 1988, Journal of virology.

[22]  D. Veber,et al.  HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. , 1988, Biochemical and biophysical research communications.

[23]  P. Earl,et al.  Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. , 1988, Virology.

[24]  M. Johnson,et al.  Conserved cysteine and histidine residues of the avian myeloblastosis virus nucleocapsid protein are essential for viral replication but are not "zinc-binding fingers". , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Miller,et al.  Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions , 1988, Journal of virology.

[26]  S. Goff,et al.  Gene product of Moloney murine leukemia virus required for proviral integration is a DNA-binding protein. , 1988, Journal of molecular biology.

[27]  E. Gouilloud,et al.  Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes , 1988, Journal of virology.

[28]  S. Kent,et al.  Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease , 1988, Cell.

[29]  J. Hansen,et al.  Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. , 1988, The EMBO journal.

[30]  H. Varmus,et al.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression , 1988, Nature.

[31]  S. Goff,et al.  Sequence and spacing requirements of a retrovirus integration site. , 1988, Journal of molecular biology.

[32]  H. Temin,et al.  Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line , 1987, Journal of virology.

[33]  L. Madisen,et al.  Expression of the human immunodeficiency virus gag gene in insect cells. , 1987, Virology.

[34]  M. Bender,et al.  Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region , 1987, Journal of virology.

[35]  Armentano,et al.  Effect of internal viral sequences on the utility of retroviral vectors , 1987, Journal of virology.

[36]  R. Karpel,et al.  Interactions of retroviral structural proteins with single-stranded nucleic acids. , 1987, The Journal of biological chemistry.

[37]  T. Copeland,et al.  Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. , 1987, AIDS research and human retroviruses.

[38]  A. Skalka,et al.  A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging , 1986, Journal of virology.

[39]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[40]  J. Berg,et al.  Potential metal-binding domains in nucleic acid binding proteins. , 1986, Science.

[41]  E. Reddy,et al.  HTLV-III gag protein is processed in yeast cells by the virus pol-protease. , 1986, Science.

[42]  S. Covey Amino acid sequence homology in gag region of reverse transcribing elements and the coat protein gene of cauliflower mosaic virus. , 1986, Nucleic acids research.

[43]  Amanda G. Fisher,et al.  A molecular clone of HTLV-III with biological activity , 1985, Nature.

[44]  W. Craigen,et al.  Bacterial peptide chain release factors: conserved primary structure and possible frameshift regulation of release factor 2. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Baltimore,et al.  Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs , 1985, Journal of virology.

[46]  S. Goff,et al.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins , 1985, Journal of virology.

[47]  J. Coffin,et al.  Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication , 1985, Molecular and cellular biology.

[48]  Thomas A. Kunkel,et al.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Yanisch-Perron,et al.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.

[50]  S. Goff,et al.  Construction and analysis of deletion mutations in the pol gene of moloney murine leukemia virus: A new viral function required for productive infection , 1984, Cell.

[51]  F. Harada,et al.  Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants , 1984, Journal of virology.

[52]  J. Darlix,et al.  It is Rous sarcoma virus protein P12 and not P19 that binds tightly to Rous sarcoma virus RNA. , 1984, Journal of molecular biology.

[53]  S. Goff,et al.  Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase , 1984, Journal of virology.

[54]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[55]  S. Hughes,et al.  cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus , 1983, Journal of virology.

[56]  D. Stacey,et al.  Identification of a sequence likely to be required for avian retroviral packaging. , 1983, Virology.

[57]  F. Studier,et al.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements. , 1983, Journal of molecular biology.

[58]  D. Baltimore,et al.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.

[59]  H. Temin,et al.  Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Barkley,et al.  Ion effects on the lac repressor--operator equilibrium. , 1981, Biochemistry.

[61]  W. N. Burnette,et al.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. , 1981, Analytical biochemistry.

[62]  M. Hayman,et al.  Analysis of cells transformed by defective leukemia virus OK10: production of noninfectious particles and synthesis of Pr76gag and an additional 200,000-dalton protein. , 1980, Virology.

[63]  R. Eisenman,et al.  Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses , 1980, Journal of virology.

[64]  W. N. Burnette,et al.  Synthesis and processing of viral glycoproteins in two nonconditional mutants of Rous sarcoma virus , 1980, Journal of virology.

[65]  W. S. Hayward,et al.  An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: Biological and biochemical characterization , 1978, Cell.

[66]  D. Baltimore,et al.  High frequency of aberrant expression of moloney murine leukemia virus in clonal infections , 1978, Cell.

[67]  W. N. Burnette,et al.  Stoichiometry and specificity of binding of Rauscher oncovirus 10,000-dalton (p10) structural protein to nucleic acids , 1978, Journal of virology.

[68]  T. Lebien RNA Tumor Viruses , 1975 .

[69]  I. K. Berezesky,et al.  Deficiency of 60 to 70S RNA in Murine Leukemia Virus Particles Assembled in Cells Treated with Actinomycin D , 1974, Journal of virology.

[70]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.